Publications by authors named "P O'Regan"

Chest ports are typically inserted via the right internal jugular vein with the left side being utilized in certain patient populations. The purpose of this study was to evaluate the dynamic position of the chest port and catheter tip, comparing a demographically matched cohort of female breast cancer patients with right- or left-sided chest ports. 142 female patients with breast cancer requiring chest port insertion for chemotherapy and imaging confirming catheter tip position initially with supine fluoroscopy and follow-up with erect chest radiography over a 5-year period were identified.

View Article and Find Full Text PDF

Aim: Idiopathic pulmonary fibrosis (IPF) is a debilitating and fatal lung disease. Changes in body composition potentially correlate with outcomes in patients with IPF.

Materials And Methods: Patients with IPF on antifibrotic treatment attending a single institution were identified and retrospectively evaluated (n=84).

View Article and Find Full Text PDF

The diagnosis of suspected physical abuse (SPA) remains a continuous challenge to paediatric healthcare. Several studies have reported that computed tomography (CT) improves the evaluation of SPA. This study aims to systematically review the diagnostic performance of CT compared to radiography in investigating skull and chest fractures for SPA.

View Article and Find Full Text PDF

Background: Incidental pulmonary nodules are an increasingly common finding on computed tomography (CT) scans of the thorax due to the exponential rise in CT examinations in everyday practice. The majority of incidental pulmonary nodules are benign and correctly identifying the small number of malignant nodules is challenging. Ultra-low-dose CT (ULDCT) has been shown to be effective in diagnosis of respiratory pathology in comparison with traditional standard dose techniques.

View Article and Find Full Text PDF
Article Synopsis
  • PROACT 2.0 is an open-source mobile and web application designed to improve communication between cancer patients and healthcare providers during clinical trials.
  • Developed by Fondazione IRCCS Istituto Nazionale Tumori in Milan and The Christie in Manchester, it is part of the UpSMART Accelerator project involving various oncology centers in Europe.
  • The app allows patients to report side effects and adverse events using text, audio, and video, creating a secure communication channel that enhances patient engagement and streamlines information management in cancer treatment.
View Article and Find Full Text PDF